[Heparinization in dialysis: new clinico-therapeutic directions].
The authors describe side-effects of heparin administration during chronic dialytic treatment. For every complication they present a new clinical and therapeutic guideline. They then illustrate their method for monitoring heparin therapy with partial activated thromboplastin time and low dose heparin combined with prostacyclin.
Camici
M
M
Insegnamento Metodologia Clinca Medica, Università degli Studi di Pisa.
Evangelisti
L
L
D001792:Blood Platelets / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D050356:Lipid Metabolism; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects; D010024:Osteoporosis / Q000139:chemically induced; D006435:Renal Dialysis
D000451:Mineralocorticoid Receptor Antagonists; D006493:Heparin
Eparinizzazione in dialisi: nuovi orientamenti clinico-terapeutici.